Press releaseGlobe Newswire
Cronos Group
CRON · TORONTO
$3.35−$0.095 (−2.76%)TodayMarket closed ·
Prev close $3.45
Latest news
- Press releaseGlobe Newswire
Cronos Group Inc. to Hold 2026 Third Quarter Earnings Conference Call on November 5, 2026
- NewsAvi Kapoor
Mercury Systems Posts Mixed Q4 Results, Joins WhiteFiber And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session
- News
Cronos Group Q2 EPS $0.09 Beats $0.01 Estimate, Sales $53.007M Beat $44.200M Estimate
- Press releaseGlobe Newswire
Cronos Group Reports 2026 Second Quarter Results
- Press releaseGlobe Newswire
Cronos Group Inc. to Hold 2026 Second Quarter Earnings Conference Call on August 6, 2026
- NewsAvi Kapoor
Nike, Shutterstock And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session
- Press releaseGlobe Newswire
Cronos Announces Appointment of ATB Cormark as its Broker for Share Repurchases in Canada
- Press releaseGlobe Newswire
Cronos Announces Extension of Share Repurchase Program to the Toronto Stock Exchange
- News
Cronos Group Q1 EPS $0.04 Beats $0.01 Estimate, Sales $45.210M Beat $42.200M Estimate
- Press releaseGlobe Newswire
Cronos Group Reports 2026 First Quarter Results
- News
Earnings Scheduled For May 11, 2026
- NewsKaustubh Bagalkote
Why Akanda Stock Is Surging Wednesday?
- NewsAkanksha Bakshi
Akanda Shares Soar As Cannabis Stocks Rise On US Policy Change
- News
'Trump Reclassifies State-Licensed Medical Marijuana As A Less-Dangerous Drug In A Historic Shift' - AP News
- NewsMohd Haider
Akanda (AKAN) Stock Continues Soaring Overnight Amid Trump Cannabis Reclassification Report: What You Should Know
- Press releaseGlobe Newswire
Cronos Group Inc. to Hold 2026 First Quarter Earnings Conference Call on May 11, 2026
- Press releaseGlobe Newswire
Cronos Group Reports 2025 Fourth Quarter and Full-Year Results
- Press releasePRNewswire
Format Innovation Reshapes a $438B Functional Market
- NewsVandana Singh
White House Considers Cannabis Reclassification, Stops Short Of Legalization: Stocks To Watch
- NewsErica Kollmann
High Hopes: Pot Stocks Blaze As Trump Eyes Rescheduling
- News
'Trump Expected To Sign An Order Moving To Reclassify Cannabis And Open Up Medical Potential' - NBC News
- NewsNamrata Sen
Tilray, Canopy And Other Weed Stocks Are Rallying In Friday Pre-Market— What's Going On?
- NewsNamrata Sen
Trump Reportedly Plans Major Shift To Ease Federal Marijuana Rules
- Press releaseGlobe Newswire
Cronos to enter the Netherlands with acquisition of Europe's largest adult-use cannabis company
- News
UPDATE: 'Medicare to Test Making CBD Treatment Available for Seniors' - Bloomberg News
- News
NBC News Congressional Correspondent Julie Tsirkin Posts On X "POTUS "supports the current language in the bill on hemp," per WH official. Sen Rand Paul has long told leadership + industry folks he won't consent to bills unless the loophole is preserved, created by the 2018 farm bill that allows unregulated THC products to be sold nationwide"
- News
Earnings Scheduled For November 6, 2025
- NewsErica Kollmann
Top Stocks With Earnings This Week: Joby, IonQ, AMD and More
- NewsErica Kollmann
President Trump Lights Up Cannabis Stocks With Pro-CBD Truth Social Post
- NewsNabaparna Bhattacharya
What's Going On With Tilray Stock Today?
- Press releasePRNewswire
High Tide Closes on $30 Million Convertible Debt from Cronos Group Inc.
- News
'Effort to Ease Cannabis Rules Faces New Opposition From Experts'- Bloomberg
- NewsJavier Hasse
This Week In Cannabis: Earnings Divide The Market As DEA, Brands And Bills Move Forward
- News
Earnings Scheduled For May 8, 2025
- NewsJavier Hasse
Why Cannabis Stocks Jumped By Double Digits And Why Analysts Say 'Don't Drink The Kool-Aid In One Gulp'
- NewsJavier Hasse
This Week In Cannabis: Big Earnings Reports, Ice Cube's New Brand, Trump's Mixed Signals, Germany's Import Boom And Much More
- NewsVandana Singh
Cronos Q4 Sales Jump 27% On Higher Cannabis Flower And Extract Sales, Reports Improved Profitability
- NewsJavier Hasse
Cannabis Stocks Cronos, Trulieve, Green Thumb, Verano Trading Up After Earnings: A Full Recap
- Press releaseGlobe Newswire
Cronos Group Reports 2024 Fourth Quarter and Full-Year Results
- NewsNicolás Jose Rodriguez
Are You Missing Out On This NASDAQ-Listed Weed Stock? Low-Cost Model Meets European Demand
- NewsRolando García
Cronos CEO Mike Gorenstein Says He's Optimistic About Trump's Impact On Cannabis
- Press releaseGlobe Newswire
Cronos Group Reports 2024 Third Quarter Results
- Press releaseGlobe Newswire
Cronos Group Reports 2024 Second Quarter Results
- Press releaseGlobe Newswire
U.S. Cannabis Market Soars Amid Legal Reforms, But Safety Concerns Persist
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.